...
机译:基于1257名患者样本的晚期浆液性卵巢癌单基因预后标志
Department of Biostatistics, Public Health School, Harbin Medical University,Harbin, 150086, P. R. China;
Department of Biostatistics, Public Health School, Harbin Medical University,Harbin, 150086, P. R. China;
Department of Biostatistics, Public Health School, Harbin Medical University,Harbin, 150086, P. R. China;
Department of Biostatistics, Public Health School, Harbin Medical University,Harbin, 150086, P. R. China;
Department of Biostatistics, Public Health School, Harbin Medical University,Harbin, 150086, P. R. China;
Department of Biostatistics, Public Health School, Harbin Medical University,Harbin, 150086, P. R. China;
Department of Biostatistics, Public Health School, Harbin Medical University,Harbin, 150086, P. R. China;
Department of Biostatistics, Public Health School, Harbin Medical University,Harbin, 150086, P. R. China;
机译:Cyclin E1(CCNE1)作为晚期浆液性卵巢癌患者的独立阳性预后因素-OVCAD联合会的研究
机译:ADAM金属肽酶结构域12在晚期浆液性卵巢癌中的预后意义
机译:基于全基因组寡核苷酸的阵列比较基因组杂交分析确定成纤维细胞生长因子1为晚期浆液性卵巢腺癌的预后标志物。
机译:应用放射性组学方法对卵巢癌患者进行早期预后评估:初步研究
机译:基于预后和预测基因特征的亚组分析用于早期非小细胞肺癌患者的辅助化疗
机译:鉴定高级阶段血液癌癌的新型肿瘤微环境预后签名
机译:从晚期浆液性卵巢癌患者腹水中分离出的复发性卵巢肿瘤细胞的独特分子标记